CRISPR & Genetic Engineering: A New Genetic Screening Tool for Human Organoids
CRISPR & Genetic Engineering: A New Genetic Screening Tool for Human Organoids
The Knoblich lab at IMBA has developed a groundbreaking technique allowing hundreds of genes to be analyzed in parallel in human tissue. They named the …
- The Card1 nuclease provides defence during type-III CRISPR immunity – Nature.com
- TOP delivery of CRISPR-Cas9 machinery to primary T cells – Fred Hutch News Service
- 7 CRISPR Stocks for the Future of Medicine – Nasdaq
- Scientists Write ‘Hello World’ in Bacterial DNA With Electricity and CRISPR – Smithsonian Magazine
- One Step Closer to CRISPR-Cas9 Cancer Therapies – Technology Networks
- Digital information written directly into cells’ genomes using CRISPR – Chemical & Engineering News
- With Rare Speed, Gene Editing Emerges as Biotech’s New Cutting Edge – Barron’s
- CRISPR gene-editing urgently needs an off-switch – now we have one – New Scientist
- CRISPR: three new developments in the world of gene editing – Drug Target Review
- With durable monkey data, Verve selects its first CRISPR base editing treatment for human trials – STAT
- Detecting CRISPR-Cas9 Gene Doping in Athletes – Laboratory Equipment
- Electricity and CRISPR used to write data to bacterial DNA – Ars Technica
- Newly Studied Proteins Expand CRISPR’s Editing Range – Scientific American
- CRISPR gene editing used to store data in DNA inside living cells – New Scientist News
- CRISPR, Editas, Intellia: Gene Editing Stocks To Play The Next Revolution In Medicine – Forbes
